A model for breast cancer risk based on stem-cell theory

Current Oncology

Volumn 19, Issue 1, 2012, Pages 9-11

  Narod, Steven A ^a   Foulkes, William D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CARCINOGEN; DENOSUMAB; DIETHYLSTILBESTROL; ESTROGEN; PROGESTERONE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MENARCHE; RADIATION; RISK ASSESSMENT; STEM CELL;

EID: 84856821001     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.1003     Document Type: Article

References (22)

1. Joshi PA, Jackson HW, Beristain AG, et al. Progesterone induces adult mammary stem cell expansion. Nature 2010;465:803-7.
2. Asselin-Labat ML, Vaillant F, Sheridan JM, et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010;465:798-802.
3. Schramek D, Leibbrandt A, Sigl V, et al. Osteoclast differentiation factor rankl controls development of progestin-driven mammary cancer. Nature 2010;468:98-102.
4. Van Keymeulen A, Rocha AS, Ousset M, et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011;479:189-93.
5. Cavalieri EL, Rogan EG. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer. J Steroid Biochem Mol Biol 2011;125:169-80.
6. Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990;46:796-800.
7. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 2002;11:953-71.
8. Narod SA. Early-onset breast cancer: what do we know about the risk factors? A Countercurrents Series. Curr Oncol 2011;18:204-5.
9. Huo D, Melkonian S, Rathouz PJ, Khramtsov A, Olopade OI. Concordance in histological and biological parameters between first and second primary breast cancers. Cancer 2011;117:907-15.
10. Beral V, Reeves G, Bull D, Green J; Million Women Study Collaborators. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 2011;103:296-305.
11. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 2011;8:669-76.
12. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 2002;360:187-95.
13. Kleinerman RA. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol 2006;36(suppl 2):121-5.
14. Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 2011;306:1884-90.
15. Fernandez-Valdivia R, Lydon JP. From the ranks of mammary progesterone mediators, rankl takes the spotlight. Mol Cell Endocrinol 2011;:[Epub ahead of print].
16. Speit G, Trenz K. Chromosomal mutagen sensitivity associated with mutations in BRCA genes. Cytogenet Genome Res 2004;104:325-32.
17. Foulkes WD. BRCA1 functions as a breast stem cell regulator. J Med Genet 2004;41:1-5.
18. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. "Hormonal" risk factors, "breast tissue age" and the ageincidence of breast cancer. Nature 1983;303:767-70.
19. Trichopoulos D. Is breast cancer initiated in utero? Epidemiology 1990;1:95-6.
20. Trichopoulos D, Lagiou P, Adami HO. Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 2005;7:13-17.
21. Hoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011;365:1304-14.
22. Iqbal J, Ginsburg OM, Wijeratne TD, et al. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev 2011;:[Epub ahead of print].